Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Schwarz Pharma establishes 275m euro credit facility

Schwarz Pharma establishes 275m euro credit facility

13th December 2005

Schwarz Pharma has established a 275 million euro revolving credit facility.

The five-year facility is the company’s first and is intended for general corporate purposes.

Schwarz has appointed Barclays Capital, Dresdner Kleinwort Wasserstein and WestLB as joint book runners and joint mandated lead arrangers.

Detlef Thielgen, Schwarz Pharma chief financial officer, said: “We are very satisfied with our debut in the syndicated loan market.

“This gives us a medium term basis financing, allows us to optimise or financing structure at attractive terms and to keep financial flexibility for the future.”

The company is to invest in development projects targeting diseases such as Parkinson’s disease, Restless Legs Syndrome, epilepsy, neuropathic pain and overactive bladder syndrome.

The credit facility was marketed to selected banks and was substantially over subscribed. It benefits from two one-year extension options after years one and two.

track© Adfero Ltd

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.